NCT01481532View on ClinicalTrials.gov

Open Label Clinical Trial of Intravenous Crotoxin Part 3

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cancer
Interventions
DRUG

Crotoxin

Intra patient dose escalation

Trial Locations (1)

44805

Institut de Cancérologie de l'Ouest, Saint-Herblain

Sponsors

Lead Sponsor

Celtic Biotech Ltd
All Listed Sponsors
collaborator

Institut de Cancérologie de l'Ouest

UNKNOWN

lead

Celtic Biotech Ltd

INDUSTRY